Skip to main content
. Author manuscript; available in PMC: 2021 May 31.
Published in final edited form as: Biomaterials. 2020 Feb 7;238:119853. doi: 10.1016/j.biomaterials.2020.119853

Fig. 7.

Fig. 7.

Inhibition of tumor-stromal interactions. (A) Confocal z-projected images of the CXCR4+TNBC cells in CXCL12+HMFs-containing microtissues without and with AMD3100 treatment. (B) Normalized invasion area for AMD3100-treated and non-treated microtissues. *p<0.01 was calculated using two-tailed, unpaired t-test with n=8. (C) Western blot analysis of effect of AMD3100 treatment on ERK1/2 activity. The graph shows quantified phospho-protein levels after normalizing with t-ERK1/2. Data represent three separate experiments. *p<0.05 and ***p<0.0001 were calculated using two-tailed, unpaired t-test.